American Association for Respiratory Care. Clinical practice guideline: spirometry. Respir Care1991;136: 1414–1417.
2.
American Thoracic Society. Standardization of spirometry-1987 update. Am Rev Respir Dis1987;136:1039–1060. Published concurrently in Respir Care 1987;32(11): 1039–1060.
3.
American Thoracic Society. Standardization of spirometry 1994 update. Am J Respir Crit Care Med1995;152 (3):1107–1136.
4.
FerrisBG. Epidemiology standardization project. Am Rev Respir Dis1979;118(Suppl):7–13.
5.
American Thoracic Society. Evaluation of impairment/ disability secondary to respiratory disorders. Am Rev Respir Dis1986;133(6):1205–1209.
6.
ZibrakJD, O'DonnellCR, MartonK.Indications for pulmonary function testing. Ann Intern Med1990; 112:793–794.
7.
HankinsonJL. Pulmonary function testing in the screening of workers: guidelines for instrumentation, performance, and interpretation. J Occup Med1986; 28:1081–1082.
8.
CrapoRO. Pulmonary function testing. N Engl J Med1994;331: 25–30.
MontenegroHD, ChesterEH, JonesPK. Cardiac arrhythmias during routine tests of pulmonary function in patients with chronic obstruction of airways. Chest1978;73:133–139.
11.
HankinsonJL, BangKM. Acceptability and reproducibility criteria of the American Thoracic Society as observed in a sample of the general population. Am Rev Respir Dis1991;143(3):516–521.
12.
EnrightPL, JohnsonLR, ConnettJE, VoelkerH, BuistAS. Spirometry in the lung health study: 1. Methods and quality control. Am Rev Respir Dis1991;143(6): 1215–1223.
13.
CasaburiR, AdameD, HongCK. Comparison of albuterol to isoproterenol as a bronchodilator for use in pulmonary function testing. Chest1991;100:1597–1600.
14.
LightRW, ConradSA, GeorgeRB. Clinical significance of pulmonary function tests-the one best test for evaluating the effects of bronchodilator therapy. Chest1977;72:512–516.
15.
DalesRE, SpitzerWO, TousignantP, SchechterM, SuissaS.Clinical interpretation of airway response to bronchodilator: epidemiologic considerations. Am Rev Respir Dis1988;138(2):317–320.
16.
ShimC.Response to bronchodilators. Clin Chest Med1989;10:155–164.
17.
WaalkensHJ, MerkusPJE, can Essen-ZandvlietEEM, et al. Assessment of bronchodilator response in children with asthma. Eur Respir J1993;6:645–651.
18.
American Thoracic Society Workshop on Lung Function Testing, BecklareM, CrapoRO, co-chairpersons.
19.
American Association for Respiratory Care. Clinical practice guideline: assessing response to bronchodilator therapy at point of care. Respir Care1995;40:1300–1307.
20.
HepperNGG, BlackLF, FowlerWS. Relationship of lung volume to height and arm span in normal subjects and in patients with spinal deformity. Am Rev Respir Dis1965;91:356–362.
21.
McKayRT, LockeyJE. Pulmonary function testing: guidelines for medical surveillance and epidemiological studies. Occup Med1991;6:43–57.
22.
MorrisAH, KannerRE, CrapoRO, GardnerRM. Clinical pulmonary function testing: a manual of uniform laboratory procedures, 2nd ed. Intermountain Thoracic Society, 1984, Salt Lake City.
23.
American Association for Respiratory Care. Clinical practice guideline: resuscitation in acute care hospitals. Respir Care1993;38(11):1169–1200.
24.
GlindmeyerHW, JonesRN, BarkmanHW, WeillH.Spirometry: quantitative test criteria and test acceptability. Am Rev Respir Dis1987;136(2):449–452.
25.
ShigeokaJW. Calibration and quality control of spirometer systems. Respir Care1983;28(6):747–753.
26.
Centers for Disease Control. Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other blood borne pathogens in health care settings. MMWR1988;37: 377–388.
27.
Centers for Disease Control. Summary: recommendations for preventing transmission of infection with human T-lymphotrophic virus type III/lymphadenopathy-associated virus in the workplace. MMWR1985; 34:681,686, 691–695.
28.
GarnerJS, FaveroMS. CDC guidelines for the prevention and control of nosocomial infections: guideline for hand washing and hospital environmental control. Am J Infect Control1986;14:110–129.
29.
TablanOC, WilliamsWW, MartoneWJ. Infection control in pulmonary function laboratories. Infect Control1985;6:442–444.
30.
RutalaDR, RutalaWA, WeberDR, et al. Infection risks associated with spirometry. Infection Control Hospital Epidemiol1991;12:89–92.
31.
Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health care facilities, 1994. MMWR1994; 43:1–32.
32.
Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994. MMWR1994; 43:1–132.
33.
JohnsDP, IngramC, BoothH, WilliamsTJ, WaltersEH. Effect of a microaerosol barrier filter on the measurement of lung function. Chest1995;107(4): 1045–1048.
34.
FusoL, AccardoD, BevignaniG, et al. Effects of a filter at the mouth on pulmonary function tests. Eur Respir J1995; 8:314–317.